Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
Rasha Al‐Lamee(Imperial College Healthcare NHS Trust), Yousif Ahmad(Imperial College London), Christopher Baker(Sphere Institute), Michael Mielewczik(Imperial College London), Ricardo Petraco(Imperial College London), Simon Thom(St Mary's Hospital), Robert Gerber(East Sussex Healthcare NHS Trust), Roland Wensel(Medizinische Hochschule Hannover), Kare Tang(Essex Cardiothoracic Centre), Christopher Cook(Imperial College London), Raffi Kaprielian(Imperial College Healthcare NHS Trust), James P. Howard(Imperial College Healthcare NHS Trust), Sukhjinder Nijjer(Imperial College London), Iqbal Malik(Imperial College Healthcare NHS Trust), Thomas Keeble(Essex Cardiothoracic Centre), Suneel Talwar(Royal Bournemouth and Christchurch Hospitals NHS Foundation Trust), David Collier(University of London), Jamil Mayet(Imperial College Healthcare NHS Trust), Hakim‐Moulay Dehbi(MRC Clinical Trials Unit at UCL), Dárrel P. Francis(Lung Institute), Rodney A. Foale(Hammersmith Hospital), Sayan Sen(Imperial College Healthcare NHS Trust), Justin E. Davies(Lung Institute), Ravi Assomull(Imperial College Healthcare NHS Trust), Amarjit Sethi(Imperial College Healthcare NHS Trust), Andrew Sharp(University Hospital of Wales), Ramrakha Punit(East Sussex Healthcare NHS Trust)
Cited by 1,016
Related Papers
Hypothermia versus Normothermia after Out-of-Hospital Cardiac Arrest
|New England Journal of Medicine|2021|979
Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk
|Nature Genetics|2017|589
Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
|The Lancet Diabetes & Endocrinology|2018|340